Overview

AION Biosciences develops tools that use sound and light-based fields to influence bioelectric states in living tissue. Its main products are bioelectric-modulation hardware and research-grade technology that can read, write, and steer cellular electrical activity. The system includes closed-loop hardware and custom MRI-like imaging equipment, including RF coils, gradient systems, and pulse sequences, designed for experiments on cells, tissues, and eventually humans. By interfacing with the electrical signals of cells, the platform aims to guide tissue development and cell reprogramming, offering a potential layer of control beyond chemistry or gene therapy. The company targets biomedical researchers and healthcare innovators and is funded by venture capital to advance this platform toward aging control and regenerative medicine goals.